WaveMan
WaveMan · Company
BKD · Brookdale Senior Living Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

BKD Brookdale Senior Living (BKD) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-nursing & personal care facilities · CIK 0001332349
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
160
13F, latest reported quarter

Brookdale Senior Living insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Brookdale Senior Living Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
WIELANSKY LEE S
Director
SELL
2025-05-20 SECtraded 2025-05-19
10,000
$68.2K
+45.3%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Mar 7, 2025.
  • The trade is 4.5% of the 223,836 shares held after it.
  • No other insider sold within 30 days.
  • 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WIELANSKY LEE S sold about $68.2K of BKD on May 19, 2025, the largest insider sale at the company since 2024; 160 funds added in the latest 13F quarter.
WIELANSKY LEE S
Director
SELL
2025-03-10 SECtraded 2025-03-07
10,000
$58.4K
+69.3%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Dec 5, 2024.
  • The trade is 4.3% of the 233,836 shares held after it.
  • No other insider sold within 30 days.
  • 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WIELANSKY LEE S sold about $58.4K of BKD on Mar 7, 2025, the largest insider sale at the company since 2024; 160 funds added in the latest 13F quarter.
WIELANSKY LEE S
Director
SELL
2024-12-06 SECtraded 2024-12-05
10,000
$56.2K
+73.9%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 4.7% of the 211,382 shares held after it.
  • No other insider sold within 30 days.
  • 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WIELANSKY LEE S sold about $56.2K of BKD on Dec 5, 2024; 160 funds added in the latest 13F quarter.
BROMLEY MARCUS E
Director
SELL
2024-05-17 SECtraded 2024-05-15
3,300
$23.9K
+38.9%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Feb 27, 2024.
  • The trade is 2.3% of the 146,152 shares held after it.
  • No other insider sold within 30 days.
  • 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director BROMLEY MARCUS E sold about $23.9K of BKD on May 15, 2024; 160 funds added in the latest 13F quarter.
HICKS GEORGE T
EVP & Treasurer
BUY
2024-03-06 SEC
9,140
$50.3K
+62.9%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Dec 3, 2021.
  • The trade is 2.6% of the 351,883 shares held after it.
  • 1 other insider bought within 30 days.
  • 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Treasurer HICKS GEORGE T bought about $50.3K of BKD on Mar 6, 2024, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 160 funds added in the latest 13F quarter.
16 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 11 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
160 funds bought in last quarter
more than 65% of Healthcare Services
Revenue
+2.2% year over year
below 73% of Healthcare Services
Margin
-8.2% net margin
below 68% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
19.4% of the float short (float per yahoo 2026-10-27) · 6.7 days to cover · settled 2026-10-15
more than 95% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch BKD

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+9.3%12M
+0%+31%+62%+92%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns BKD: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
23,648,712 sh
$380.5M
WCM INVESTMENT MANAGEMENT, LLC
14,453,030 sh
$229.2M
DEERFIELD MANAGEMENT COMPANY, L.P.
11,637,032 sh
$187.2M
ANTIPODES PARTNERS Ltd
11,091,757 sh
$178.5M
VANGUARD PORTFOLIO MANAGEMENT LLC
10,817,723 sh
$174.1M

Congress trades in BKD

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

BKD planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

BKD mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Polen 5Perspectives Small Growth Fund
$1.9M position · as of 2026-07-31
3.0%
Third Avenue Real Estate Value Fund
$7.7M position · as of 2026-07-31
2.5%
JNL Multi-Manager Select Equity Fund
$36.0M position · as of 2026-06-30
2.3%
Counterpoint Quantitative Equity ETF
$7.4M position · as of 2026-06-30
2.0%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$2.8M position · as of 2026-06-30
2.0%
NVIT Real Estate Fund
$3.9M position · as of 2026-06-30
1.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Brookdale Senior Living Pac
Cycle 2026 · $5K spent
$67.8K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Baier
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$9.8M
$6.4M
$1.6M
+14%
+29%
2023
$5.5M
$12.8M
$1.3M
+31%
+26%
2022
$6.6M
$3.0M
$1.5M
-38%
+24%
2021
$5.3M
$6.0M
$1.2M
+16%
+26%
2020
$7.1M
$721
$2.0M
-39%
+13%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 160 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

BKD financials

Revenue growth
+2.2%
XBRL, annual
Net margin
-8.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.1B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-4.5%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$23.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
0.05x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
-362.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-2.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
+1.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$6.2B
market value at close 2026-10-27 on 2026-08-06 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+1.0%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$3.2B$3.1B$3.0B$2.8B
Gross profit$837.5M$799.3M$746.7M$594.4M
Operating income$13.5M$46.5M$18.4M-$42.7M
Net income-$262.7M-$201.9M-$189.0M-$238.4M
EPS (diluted)-1.12-0.89-0.84-1.25
Operating cash flow$218.0M$166.2M$162.9M$3.3M
Cash$279.1M$308.9M$278.0M$398.9M
Long-term debt$4.2B$4.0B$3.7B$3.8B
Buybacksn/an/an/a$0
SEC XBRL, fiscal years, as known on 2026-10-28

BKD Stock Sonar score 5/7 axes

Find similar shapesCompare

BKD ranks highest on risk and compliance (48th percentile) and institutional and government (45th), and lowest on growth (27th), among Healthcare Services peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
36
Inputs
  • Return on equity-362.1% · 7 pct, sector of 70
  • Return on assets-2.3% · 51 pct, sector of 88
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed+1.9% · 49 pct, sector of 68
Financial health
40
Inputs
  • Debt to equityequity is zero or negative, the ratio has no meaning
  • Cash flow to debt0.05x · 40 pct, sector of 66
Growth
27
Inputs
  • Revenue growth, YoY+2.2% · 27 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
45
Inputs
  • Funds adding, latest quarter160 · 65 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$160K · 25 pct, universe of 1,062
Risk and compliance
48
Inputs
  • Short interest, % of float+19.4% · 7 pct, sector of 93
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+4.0% · 90 pct, sector of 72
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies